-
-
[1]Iredale JP.Cirrhosis;new research provides a basis for rational andtargeted treatments[J].BMJ, 2003, 327 (19) ∶143-7. [2] 姚希贤.肝纤维化的基础与临床[M].上海:上海科技教育出版社, 2003∶1-9. [3]Greener AM.Cytokines and celluar crostalk involed in the activationof fat-storing cells[J].Hapatol, 1995, 22 (suppl 2) ∶28-36. [4]Beljaars L, Meijer DK, Poelstra K.Targeting hepatic stellate cellsfor cell-specific treatment of liver fibrosis[J].Front Biosci, 2002, 7∶214-222. [5]Dienstag J, Schiff E, Wright T.Lamivudine as initial treatment forchronic hepatitis B in the United States[J].N Engl J Med, 1999, 341∶1256-1263. [6]Kweon YO, Goodman ZD, Dienstag JL, et al.Decreasing fibrogene-sis:an immunohistochemical study of paired liver biopsies followinglamivudine therapy for chronic hepatitis B[J].Hepatol, 2001, 35∶749-755.
本文二维码
计量
- 文章访问数: 2020
- HTML全文浏览量: 8
- PDF下载量: 826
- 被引次数: 0